NFE2L2 and Parkinson disease: Additionally, via activating the Nrf2/HO1 signaling pathway, BCP mitigated focal cerebral ischemia-reperfusion damage [20], MPTP induced Parkinson’s disease [51], aflatoxin B1 induced liver toxicity [48], and sulfasalazine-induced nephrotoxicity [49].